and/or

33 Blog posts found

In the Lab

CRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level

What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.

CAR T cells attacking cancer

Feature

T Is for T Cell: The Science Behind Immunotherapy

By deciphering the biology of T cells, MSK scientists gave immunotherapy a boost.

T cells on the loose.

In the Lab

Researchers Gain Insight into How a Drug Fires Up an Immune Response to Cancer

Scientists have learned that a drug activates a form of highly inflammatory programmed cell death called pyroptosis — a discovery that sheds light on immune function.

Image of fireball-type explosion on black background.

Q&A

New Approach Could Boost Immunotherapy for Breast Cancer

A protein on certain immune cells is a promising target for making immunotherapy more effective against breast cancer.

Illustration of immune cell opening as if on hinge and boxing glove coming out.

In the Clinic

Targeting Pancreatic Cancer: An Increased Focus on Developing New Clinical Trials

Pancreatic cancer is difficult to treat, but researchers are focused on developing treatments that are personalized based on each individual patient’s disease.

Feature

Do Cancer Vaccines Have a Shot at Success?

After a string of failures, therapeutic cancer vaccines have acquired something of a bad rap. Can we do better?

Needle entering a vaccine vial.

In the News

Symposium Held at MSK Honors Alexander Rudensky, Pioneering Immunologist

One of MSK’s leading immunologists turned 60 on Friday, and scientists came to celebrate.

In the Lab

Origin Story: Finding on Macrophage Development Challenges Long-Held View

A surprising finding challenges long-held dogma about how certain immune cells develop into specialized types in diverse tissues.

Electronic microscope enlargement of macrophage cell (tinted green)

Feature

Microorganisms in the Gut Can Affect Cancer Outcomes

Discover how microbiome research is revealing the role that bacteria play in cancer treatment.

rod-shaped bacteria

Announcement

MSK Is Named Founding Member of Parker Institute for Cancer Immunotherapy

Cancer immunotherapy got a big boost today in the form of a $250 million grant from the Parker Foundation and a new brain trust composed of the world’s top scientists.

Sean Parker